These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31177183)

  • 1. Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study.
    Behary P; Tharakan G; Alexiadou K; Johnson N; Wewer Albrechtsen NJ; Kenkre J; Cuenco J; Hope D; Anyiam O; Choudhury S; Alessimii H; Poddar A; Minnion J; Doyle C; Frost G; Le Roux C; Purkayastha S; Moorthy K; Dhillo W; Holst JJ; Ahmed AR; Prevost AT; Bloom SR; Tan TM
    Diabetes Care; 2019 Aug; 42(8):1446-1453. PubMed ID: 31177183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction.
    Jones B; Sands C; Alexiadou K; Minnion J; Tharakan G; Behary P; Ahmed AR; Purkayastha S; Lewis MR; Bloom S; Li JV; Tan TM
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e767-e782. PubMed ID: 34460933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers.
    Tan T; Behary P; Tharakan G; Minnion J; Al-Najim W; Albrechtsen NJW; Holst JJ; Bloom SR
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2364-2372. PubMed ID: 28379519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single-blind placebo-controlled study.
    Behary P; Alessimii H; Miras AD; Tharakan G; Alexiadou K; Aldhwayan MM; Purkayastha S; Moorthy K; Ahmed AR; Bloom SR; Tan TM
    Diabetes Obes Metab; 2023 Jun; 25(6):1731-1739. PubMed ID: 36811311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes.
    Shankar SS; Shankar RR; Mixson LA; Miller DL; Pramanik B; O'Dowd AK; Williams DM; Frederick CB; Beals CR; Stoch SA; Steinberg HO; Kelley DE
    Diabetes; 2018 Jun; 67(6):1105-1112. PubMed ID: 29545266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Hormone Responses to Mixed Meal Test in New-Onset Prediabetes/Diabetes After Acute Pancreatitis.
    Pendharkar SA; Singh RG; Cervantes A; DeSouza SV; Bharmal SH; Petrov MS
    Horm Metab Res; 2019 Mar; 51(3):191-199. PubMed ID: 30572349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.
    Tharakan G; Behary P; Wewer Albrechtsen NJ; Chahal H; Kenkre J; Miras AD; Ahmed AR; Holst JJ; Bloom SR; Tan T
    Eur J Endocrinol; 2017 Dec; 177(6):455-464. PubMed ID: 28855269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
    Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
    Lips MA; de Groot GH; van Klinken JB; Aarts E; Berends FJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Willems van Dijk K; Pijl H
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):834-42. PubMed ID: 23711328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bariatric surgery combined with medical therapy versus intensive medical therapy or calorie restriction and weight loss on glycemic control in Zucker diabetic fatty rats.
    Abegg K; Corteville C; Docherty NG; Boza C; Lutz TA; Muñoz R; le Roux CW
    Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R321-9. PubMed ID: 25540099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
    Aaboe K; Knop FK; Vilsbøll T; Deacon CF; Holst JJ; Madsbad S; Krarup T
    Diabetes Obes Metab; 2010 Apr; 12(4):323-33. PubMed ID: 20380653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
    Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
    Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in glycemia, insulin and gut hormone responses to a slowly ingested solid low-carbohydrate mixed meal after laparoscopic gastric bypass or band surgery.
    Bunt JC; Blackstone R; Thearle MS; Vinales KL; Votruba S; Krakoff J
    Int J Obes (Lond); 2017 May; 41(5):706-713. PubMed ID: 28119531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxyntomodulin and Glicentin May Predict the Effect of Bariatric Surgery on Food Preferences and Weight Loss.
    Nielsen MS; Ritz C; Wewer Albrechtsen NJ; Holst JJ; le Roux CW; Sjödin A
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32016415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans.
    Field BC; Wren AM; Peters V; Baynes KC; Martin NM; Patterson M; Alsaraf S; Amber V; Wynne K; Ghatei MA; Bloom SR
    Diabetes; 2010 Jul; 59(7):1635-9. PubMed ID: 20357366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
    Svane MS; Bojsen-Møller KN; Martinussen C; Dirksen C; Madsen JL; Reitelseder S; Holm L; Rehfeld JF; Kristiansen VB; van Hall G; Holst JJ; Madsbad S
    Gastroenterology; 2019 May; 156(6):1627-1641.e1. PubMed ID: 30742833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial effects of consuming a staggered meal on gut peptide and glycemic responses in obese women and men.
    Griffith L; Haddad EH; Tonstad S
    Obes Res Clin Pract; 2016; 10(3):264-74. PubMed ID: 26311660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.